TVTX•benzinga•
Citigroup Maintains Buy on Travere Therapeutics, Raises Price Target to $35
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 24, 2025 by benzinga